Ibacitabine

CAS No. 611-53-0

Ibacitabine( AI3-62629,Ibacitabin,Ibacitabine )

Catalog No. M22719 CAS No. 611-53-0

Ibacitabine is a drug with the activity of antiviral.It is a compound used in the construction of DNA oligomers.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 37 In Stock
100MG 27 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ibacitabine
  • Note
    Research use only, not for human use.
  • Brief Description
    Ibacitabine is a drug with the activity of antiviral.It is a compound used in the construction of DNA oligomers.
  • Description
    Ibacitabine is a drug with the activity of antiviral.It is a compound used in the construction of DNA oligomers.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    AI3-62629,Ibacitabin,Ibacitabine
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    611-53-0
  • Formula Weight
    353.12
  • Molecular Formula
    C9H12IN3O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:Soluble
  • SMILES
    Nc1nc(=O)n(cc1I)[C@H]1C[C@H](O)[C@@H](CO)O1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Serpentier-Daude A , Collet E , Didier A F , et al. [Contact dermatitis to topical antiviral drugs][J]. Ann Dermatol Venereol, 2000, 127(2):191-193.
molnova catalog
related products
  • Tyroserleutide hydro...

    Tyroserleutide hydrochloride is a small molecule tripeptide isolated from the degradation product of pig spleen, which can inhibit tumor growth in vivo and in vitro.

  • Ropidoxuridine

    Ropidoxuridine (IPdR) is a novel, orally available halogenated thymidine analogue that holds promise as a sensitizer for human tumors.

  • Tilifodiolide

    Tilifodiolide exerts in vitro and in vivo anti-inflammatory activity and in vivo antinociceptive effects.